Clinical Trials Browser

Interventional × Kidney Neoplasms × Semaxinib × Clear all

NCT00006384 2011-10-20

SU5416 and Interferon Alfa-2b in Treating Patients With Unresectable or Metastatic Kidney Cancer

Phase 2 Completed

Carcinoma, Renal Cell, Kidney Neoplasms